Synchronous ovarian and endometrial cancer-an international multicenter case-control study

International Journal of Gynecological Cancer

Volumn 24, Issue 1, 2014, Pages 54-60

  Heitz, Florian ^a,b   Amant, Frederic ^c   Fotopoulou, Christina ^d   Battista, Marco J ^e   Wimberger, Pauline ^f,g   Traut, Alexander ^a,b   Fisseler Eckhoff, Annette ^b   Harter, Philipp ^a,b   Vandenput, Ingrid ^c   Sehouli, Jalid ^d   Schmidt, Marcus ^e   Kimmig, Rainer ^f   Du Bois, Rabea ^a,b   Du Bois, Andreas ^a,b  

^a KLINIKEN ESSEN MITTE   (Germany)

^b DR HORST SCHMIDT KLINIKEN   (Germany)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

^f UNIVERSITY OF DUISBURG ESSEN   (Germany)

^g DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Endometrial cancer; Ovarian carcinoma; Synchronous endometrial and ovarian carcinoma

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER SURVIVAL; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOMETRIUM CANCER; EUROPE; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; MULTICENTER STUDY (TOPIC); OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYNCHRONOUS ENDOMETRIAL CANCER; SYNCHRONOUS OVARIAN CANCER;

CARCINOMA; CASE-CONTROL STUDIES; COHORT STUDIES; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; GERMANY; HUMANS; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; TERTIARY CARE CENTERS;

EID: 84893671281     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000019     Document Type: Article

References (30)

1. International Agency for Research on Cancer. GLOBOCAN 2008 Lyon 2012. Available at: http://globocan.iarc.fr/ factsheet.asp. Accessed May 9, 2013.
2. Plataniotis G, Castiglione M. Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(suppl 5):v41-v45.
3. Fruscio R, Garbi A, Parma G, et al. Randomized phase III clinical trial evaluating weekly cisplatin for advanced epithelial ovarian cancer. J Natl Cancer Inst. 2011;103:347-351.
4. Creasman WT, Odicino F, Maisonneuve P, et al. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006;95(suppl 1):S105-S143.
5. Pecorelli S, Ray-Coquard I, Tredan O, et al. Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes. Ann Oncol. 2010;21:759-765.
6. Heintz AP, Odicino F, Maisonneuve P, et al. Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006;95(suppl 1):S161-S192.
7. Ulbright TM, Roth LM. Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases. Hum Pathol. 1985;16:28-34.
8. Scully R, Young R, Clement P. Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad Ligament: Atlas of Tumor Pathology. Armed Forces Institute of Pathology; Bethesda, MD. 1998:Tables 5-1-5-3.
9. AlHilli MM, Dowdy SC, Weaver AL, et al. Incidence and factors associated with synchronous ovarian and endometrial cancer: a population-based case-control study. Gynecol Oncol. 2012;125:109-113.
10. Singh N. Synchronous tumours of the female genital tract. Histopathology. 2010;56:277-285.
11. Walsh C, Holschneider C, Hoang Y, et al. Coexisting ovarian malignancy in young women with endometrial cancer. Obstet Gynecol. 2005;106:693-699.
12. Zaino R, Whitney C, Brady MF, et al. Simultaneously detected endometrial and ovarian carcinomasVa prospective clinicopathologic study of 74 cases: a gynecologic oncology group study. Gynecol Oncol. 2001;83:355-362.
13. Soliman PT, Slomovitz BM, Broaddus RR, et al. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases. Gynecol Oncol. 2004;94:456-462.
14. Sheu BC, Lin HH, Chen CK, et al. Synchronous primary carcinomas of the endometrium and ovary. Int J Gynaecol Obstet. 1995;51:141-146.
15. The International Agency for Research on Cancer. Pathology and Genetics. Tumours of the Breast and Female Genital Organs. Travassoli FA, Devilee P, eds. Lyon, France: IARC Press; 2003.
16. Mackay HJ, Brady MF, Oza AM, et al. Prognostic relevance of uncommon ovarian histology in women with stage III/IV epithelial ovarian cancer. Int J Gynecol Cancer. 2010;20:945-952.
17. Caldarella A, Crocetti E, Taddei GL, et al. Coexisting endometrial and ovarian carcinomas: a retrospective clinicopathological study. Pathol Res Pract. 2008;204:643-648.
18. Eifel P, Hendrickson M, Ross J, et al. Simultaneous presentation of carcinoma involving the ovary and the uterine corpus. Cancer. 1982;50:163-170.
19. Chiang YC, Chen CA, Huang CY, et al. Synchronous primary cancers of the endometrium and ovary. Int J Gynecol Cancer. 2008;18:159-164.
20. Pearl ML, Johnston CM, Frank TS, et al. Synchronous dual primary ovarian and endometrial carcinomas. Int J Gynaecol Obstet. 1993;43:305-312.
21. Williams MG, Bandera EV, Demissie K, et al. Synchronous primary ovarian and endometrial cancers: a population-based assessment of survival. Obstet Gynecol. 2009;113:783-789.
22. van Altena AM, Geels YP, Bulten J, et al. Why do women with double primary carcinoma of the endometrium and ovary have a favorable prognosis? Int J Gynecol Pathol. 2012;31:344-351.
23. Castro IM, Connell PP, Waggoner S, et al. Synchronous ovarian and endometrial malignancies. Am J Clin Oncol. 2000;23:521-525.
24. Nishimura N, Hachisuga T, Yokoyama M, et al. Clinicopathologic analysis of the prognostic factors in women with coexistence of endometrioid adenocarcinoma in the endometrium and ovary. J Obstet Gynaecol Res. 2005;31:120-126.
25. Halperin R, Zehavi S, Hadas E, et al. Simultaneous carcinoma of the endometrium and ovary vs endometrial carcinoma with ovarian metastases: a clinical and immunohistochemical determination. Int J Gynecol Cancer. 2003;13:32-37.
26. Ayhan A, Guvenal T, Coskun F, et al. Survival and prognostic factors in patients with synchronous ovarian and endometrial cancers and endometrial cancers metastatic to the ovaries. Eur J Gynaecol Oncol. 2003;24:171-174.
27. Vance S, Yechieli R, Cogan C, et al. The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma. Gynecol Oncol. 2012;126:16-19.
28. Jolly S, Vargas CE, Kumar T, et al. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation. Gynecol Oncol. 2006;103:87-93.
29. Wimberger P, Lehmann N, Kimmig R, et al. Impact of age on outcome in patients with advanced ovarian cancer treated within a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR). Gynecol Oncol. 2006;100:300-307.
30. Zorn KK, Bonome T, Gangi L, et al. Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer. Clin Cancer Res. 2005;11:6422-6430.